Skip to main content
JAAOS Global Research & Reviews logoLink to JAAOS Global Research & Reviews
. 2019 Nov 4;3(11):e18.00090. doi: 10.5435/JAAOSGlobal-D-18-00090

Clinical Features of Thoracic Myelopathy: A Single-Center Study

Kei Ando 1, Shiro Imagama 1,, Kazuyoshi Kobayashi 1, Kenyu Ito 1, Mikito Tsushima 1, Masayoshi Morozumi 1, Satoshi Tanaka 1, Masaaki Machino 1, Kyotaro Ota 1, Hiroaki Nakashima 1, Yoshihiro Nishida 1, Naoki Ishiguro 1
PMCID: PMC6903821  PMID: 31875198

Introduction:

Thoracic myelopathy is relatively uncommon because few degenerative changes occur as a result of the restricted range of motion surrounding the rib cage.

Methods:

A retrospective study was performed in 300 consecutive surgical cases of thoracic disorders with myelopathy treated in our department from 2000 to 2015. Girdle pain, back pain, low back pain, leg numbness, leg pain, gait disturbance, leg paresis, and bowel bladder disturbance as initial and preoperative symptoms; patellar tendon reflex, ankle tendon reflex, and ankle clonus as preoperative neurologic findings; MRI and CT findings; and surgical procedure, intraoperative findings, and postoperative recovery were investigated.

Results:

The disease distribution included ossification of the ligamentum flavum (OLF) (n = 48), ossification of the posterior longitudinal ligament (OPLL) (n = 30), OPLL with OLF (n = 27), intradural extramedullary tumor (n = 98), intramedullary spinal cord tumor (n = 64), vertebral tumor (n = 17), spinal cord herniation (n = 7), vertebral fracture (n = 4), and thoracic disk herniation (n = 5). There were notable associations of gait disturbance with OPLL and OPLL + OLF; back pain at initial diagnosis with disease at upper levels; and low back pain with disease at a lower level.

Conclusion:

These findings suggest that patients with gait disturbance, back pain, and low back pain on physical examination may have thoracic disease that results in myelopathy.


Thoracic myelopathy is relatively uncommon because few degenerative changes occur as a result of the restricted range of motion surrounding the rib cage. Disorders that can cause thoracic myelopathy include ossification of the posterior longitudinal ligament (OPLL), ossification of the ligamentum flavum (OLF), spinal tumor, spinal cord tumor, trauma, infection, thoracic disk disease, and spinal cord herniation (SCH).13 These disorders all generally require surgical intervention because of their progressive nature and poor response to conservative therapy.4,5

Thoracic myelopathy can cause symptoms such as leg pain, girdle pain, back pain, low back pain, motor and sensory deficit, and bowel bladder dysfunction. However, these symptoms mimic those of cervical or lumbar spinal disorders, and thus, thoracic myelopathy is often overlooked in a search for a cervical or lumbar etiology, which can result in delayed treatment.6,7 Misdiagnosis can also lead to a prolonged preoperative disease duration, which can result in myelopathy and cause irreversible neurologic damage.2 However, the characteristics of thoracic myelopathy have not been adequately addressed because of the low prevalence and the small number of patients treated surgically.2

Knowledge of the symptoms of thoracic myelopathy is important for early diagnosis and treatment. Therefore, in this study, we examined symptoms and physical examination findings associated with diseases that cause myelopathy at each level of the thoracic spine, with the goal of identifying factors that are associated with these diseases.

Methods

A retrospective study was performed in 300 consecutive cases of thoracic disorders with myelopathy treated at our department from 2000 to 2015 (Table 1). The study was approved by the institutional review board of our university.

Table 1.

Summary of Demographic Data in 300 Patients With Thoracic Myelopathy

Sex
 Male 166
 Female 134
Age (yr) 54.5 ± 16.2 (13-86)
Disease duration (mo) 17.0 ± 32.5 (0.5-120)
Preoperative JOA score 5.7 ± 2.8 (0-9)
Postoperative JOA score 7.5 ± 2.2 (0-11)
JOA recovery rate 38.2 ± 51.6 (−75-100)

JOA = Japanese Orthopaedic Association

Data are shown as mean ± SD with range in parentheses.

The severity of myelopathy before and after surgery was evaluated using the Japanese Orthopaedic Association (JOA) score for thoracic myelopathy (total of 11 points), which was derived from the JOA score for cervical myelopathy by eliminating the motor and sensory scores for the upper extremities.8,9 Postoperative improvement of symptoms was evaluated using the % recovery of the JOA score and the Hirabayashi method ([postoperative JOA score − preoperative JOA score]/[11 − preoperative JOA score] × 100%), with a recovery rate of 100% indicating the best postoperative improvement.

Girdle pain, back pain, low back pain, leg numbness, leg pain, gait disturbance, leg paresis, and bowel bladder disturbance (BBD) as initial and preoperative symptoms; patellar tendon reflex (PTR), ankle tendon reflex (ATR), and ankle clonus as preoperative neurologic findings; MRI and CT findings; and surgical procedure, intraoperative findings, and postoperative recovery were investigated. T1-4 was defined as the upper level, T5-8 as the middle level, and T9-12 as the lower level. The follow-up period was a minimum of 1 year.

Data were analyzed using SPSS ver. 22 (IBM SPSS Statistics 19.0; IBM). Data are presented as mean ± SD. Radiographic parameters and clinical data from 2 groups were compared by the Student t-test. Multivariate logistic regression analyses were used to calculate the odds ratios (ORs) and 95% confidence interval (CI) to identify factors associated with disease or affected level. P < 0.05 was considered significant.

Results

Clinical Manifestation

Sex, mean age at surgery, disease duration, follow-up period, preoperative and postoperative JOA score, JOA recovery rate, disease distribution, affected level, initial and preoperative symptoms, and neurologic findings are described in Tables 1 and 2. The 300 patients (166 men and 134 women) had an age range of 13 to 86 years (mean age, 54.7 years). The mean disease duration from onset to surgery was 17.0 months (range, 0.5 to 120 months). The diseases included OLF (n = 48), OPLL (n = 30), OPLL with OLF (n = 27), intradural extramedullary tumor (n = 98), intramedullary spinal cord tumor (IMSCT) (n = 64), vertebral tumor (VT) (n = 17), SCH (n = 7), vertebral fracture (VF) (n = 4), and thoracic disk herniation (TDH) (n = 5). The number of symptoms just before surgery was higher than the number of initial symptoms. Moreover, the rate of myelopathy such as leg numbness, gait disturbance, leg paresis, and BBD notably increased more than that of girdle pain, back pain, and low back pain (Table 2). There was a significant improvement in the mean JOA score from 5.7 preoperatively to 7.5 at the last follow-up postoperatively (P < 0.01), and this change gave a mean recovery rate of 38.2% (Table 1).

Table 2.

Clinical Features of Patients With Thoracic Myelopathy

Disease
 OLF 48 (16%)
 OPLL 30 (10%)
 OPLL + OLF 27 (9%)
 IET 98 (32.7%)
 IMSCT 64 (21.3%)
 VT 17 (5.7%)
 SCH 7 (2.3%)
 VF 4 (1.3%)
 TDH 5 (1.7%)
Affected level
 Upper 68 (22.6%)
 Middle 103 (34.2%)
 Lower 129 (42.9%)
Initial/preoperative symptoms
 Girdle pain 19 (6.3%)/22 (7.3%)
 Back pain 49 (16.3%)/58 (19.3%)
 Low back pain 66 (21.9%)/82 (27.2%)
 Leg numbness 159 (52.8%)/242 (80.2%)
 Leg pain 49 (16.3%)/66 (21.9%)
 Gait disturbance 78 (25.9%)/193 (64.1%)
 Leg paresis 21 (7%)/102 (33.9%)
 BBD 9 (3%)/27 (9%)
Neurologic findings
 PTR 196 (65.1%)
 ATR 179 (59.5%)
 Ankle clonus 122 (40.5%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Disease and Affected Level

Sex, age, and rates of hyper-PTR and hyper-ATR were similar among the disease groups. However, the disease duration tended to be longer for IMSCT and SCH and shorter for VT, VF, and TDH compared with other diseases. The preoperative JOA score was lower in OPLL + OLF and SCH. OLF occurred at a lower level, and OPLL and OPLL + OLF were found at a middle level most frequently. The JOA recovery rate was lower in OPLL, OPLL + OLF, and IMSCT (Table 3). For the affected levels, sex, age, disease duration, and preoperative and postoperative JOA scores were similar, but hyper-PTR, hyper-ATR, and positive ankle clonus occurred less frequently at the lower level (Table 4).

Table 3.

Patients' Demographics for Each Disease

Factor OLF OPLL OPLL + OLF IET IMSCT VT SCH VF TDH
n 48 30 27 98 64 17 7 4 5
Sex
 Male 35 (72.9%) 17 (56.7%) 14 (51.9%) 51 (52.0%) 36 (56.3%) 9 (52.9%) 2 (28.6%) 1 (25.0%) 2 (40.0%)
 Female 13 (27.1%) 13 (43.3%) 13 (48.1%) 47 (48.0%) 28 (43.8%) 8 (47.1%) 5 (71.4%) 3 (75.0%) 3 (60.0%)
Mean age (years) 56.5 ± 15.6 yr 52.3 ± 14.8 yr 52.8 ± 10.4 yr 54.9 ± 16.4 yr 44.8 ± 16.4 yr 52.3 ± 18.5 yr 54.1 ± 9.4 yr 74.3 ± 6.4 yr 54.2 ± 12.6 yr
Mean disease duration (mo) 17.4 ± 18.8 mo 10.0 ± 9.6 mo 17.4 ± 26.5 mo 19.0 ± 40.7 mo 21.3 ± 40.0 mo 7.1 ± 14.1 mo 24.4 ± 42.3 mo 5.0 ± 3.6 mo 4.4 ± 3.5 mo
Preoperative JOA score 6.2 ± 2.5 4.8 ± 2.5 3.9 ± 2.4 6.4 ± 42.8 6.2 ± 2.6 4.1 ± 2.9 3.4 ± 1.5 5.3 ± 2.6 5.8 ± 3.9
Postoperative JOA score 8.2 ± 1.9 6.8 ± 2.0 6.2 ± 1.9 8.1 ± 2.1 7.3 ± 2.4 6.8 ± 1.8 5.9 ± 2.0 7.3 ± 2.9 7.0 ± 3.5
JOA recovery rate (%) 45.8 ± 21.6 35.5 ± 17.2 34.3 ± 18.7 42.1 ± 28.0 29.3 ± 33.0 36.5 ± 18.2 32.4 ± 18.5 47.2 ± 37.4 38.2 ± 35.3
Affected level
 Upper 7 (14.6%) 8 (26.7%) 5 (18.5%) 24 (24.5%) 16 (25.0%) 7 (41.2%) 2 (28.6%) 0 (0.0%) 0 (0.0%)
 Middle 3 (6.3%) 19 (63.3%) 18 (66.7%) 29 (29.6%) 16 (25.0%) 7 (41.2%) 5 (71.4%) 1 (25.0%) 3 (60.0%)
 Lower 38 (79.2%) 3 (10.0%) 3 (11.1%) 45 (45.9%) 32 (50.0%) 3 (17.6%) 0 (0.0%) 3 (75.0%) 2 (40.0%)
Initial/preoperative symptoms
 Girdle pain 0 (0%)/0 (0%) 2 (6.7%)/2 (6.7%) 1 (3.7%)/4 (4.1%) 4 (4.1%)/2 (7.4%) 7 (10.9%)/8 (12.5%) 5 (29.4%)/6 (35.3%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%)
 Back pain 0 (0%)/2 (4.2%) 3 (10.0%)/3 (10.2%) 3 (11.1%)/3 (11.1%) 17 (17.3%)/20 (20.4%) 16 (25.0%)/17 (26.6%) 7 (41.2%)/10 (58.8%) 0 (0.0%)/0 (0.0%) 2 (50.0%)/2 (50.0%) 0 (0.0%)/0 (0.0%)
 Low back pain 8 (16.7%)/12 (25.0%) 4 (13.3%)/6 (20.0%) 2 (7.4%)/3 (11.1%) 29 (29.6%)/34 (34.7%) 16 (25.0%)/19 (29.7%) 3 (17.6%)/3 (17.6%) 1 (14.3%)/2 (28.6%) 2 (50.0%)/2 (50.0%) 2 (40.0%)/2 (40.0%)
 Leg numbness 32 (66.7%)/33 (68.8%) 18 (60.0%)/23 (76.7%) 17 (63.0%)/21 (77.8%) 45 (45.9%)/63 (64.3%) 36 (56.3%)/50 (78.1%) 6 (35.3%)/10 (58.8%) 4 (57.1%)/4 (57.1%) 0 (0.0%)/3 (25.0%) 1 (20.0%)/2 (40.0%)
 Leg pain 8 (16.7%)/10 (20.8%) 4 (13.3%)/7 (23.3%) 2 (7.4%)/4 (14.8%) 22 (22.4%)/28 (28.6%) 10 (15.6%)/12 (18.8%) 2 (11.8%)/3 (17.6%) 1 (14.3%)/1 (14.3%) 0 (0.0%)/0 (0.0%) 1 (20.0%)/3 (60.0%)
 Gait disturbance 17 (35.4%)/31 (64.6%) 14 (46.7%)/27 (90.6%) 14 (51.9%)/23 (85.2)% 17 (17.3%)/48 (49.0)% 9 (14.1%)/35 (54.7)% 3 (17.6%)/15 (88.2)% 1 (14.3%)/7 (100%) 0 (0.0%)/3 (25.0%) 2 (40.0%)/3 (60.0)%
 Leg paresis 5 (10.4%)/10 (20.8%) 2 (6.7%)/13 (43.3%) 3 (11.1%)/11 (40.7%) 4 (4.1%)/28 (28.6%) 4 (6.3%)/17 (26.6%) 1 (5.9%)/12 (70.6%) 0 (0.0%)/3 (42.9%) 0 (0.0%)/3 (25.0%) 2 (40.0%)/3 (60.0)%
 BBD 1 (2.1%)/2 (4.2%) 2 (6.7%)/4 (13.3%) 0 (0.0%)/1 (3.7%) 1 (1.0%)/9 (9.2%) 3 (4.7%)/6 (9.4%) 2 (11.8%)/4 (23.5%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%)
Neurologic findings
 Hyper-PTR 29 (60.4%) 27 (90.0%) 24 (88.9%) 48 (49.0%) 41 (64.1%) 13 (76.5%) 6 (85.7%) 3 (75.0%) 4 (80.0%)
 Hyper-ATR 25 (52.1%) 22 (73.3%) 21 (77.8%) 43 (43.9%) 41 (64.1%) 15 (88.2%) 5 (71.4%) 2 (50.0%) 4 (80.0%)
 Positive ankle clonus 16 (33.3%) 20 (66.7%) 20 (74.1%) 28 (28.6%) 24 (37.5%) 9 (52.9%) 3 (42.9%) 0 (0.0%) 4 (80.0%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, JOA = Japanese Orthopaedic Association, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Table 4.

Patients' Demographics for Each Affected Level

Factor Upper Middle Lower
n 69 102 128
Sex
 Male 42 (60.9%) 55 (53.9%) 69 (53.9%)
 Female 27 (39.1%) 47 (46.1%) 59 (46.1%)
Mean age (yr) 51.5 ± 15.2 yr 52.2 ± 15.7 yr 53.3 ± 17.1 yr
Preoperative JOA score 5.4 ± 2.9 4.9 ± 2.6 17.3 ± 35.9 mo
Mean disease duration (mo) 20.0 ± 39.2 mo 13.6 ± 20.6 mo 6.6 ± 2.5
Postoperative JOA score 7.4 ± 2.3 6.9 ± 2.1 8.1 ± 2.2
JOA recovery rate (%) 41.8 ± 27.0 34.1 ± 19.7 39.3 ± 30.7
Initial/preoperative symptoms
 Girdle pain 12 (17.4%)/15 (21.7%) 7 (6.9%)/7 (6.9%) 0 (0.0%)/0 (0.0%)
 Back pain 21 (30.4%)/28 (40.6%) 24 (23.5%)/26 (25.5%) 4 (3.1%)/4 (3.1%)
 Low back pain 4 (5.8%)/8 (11.6%) 9 (8.8%)/12 (11.8%) 53 (41.4%)/62 (48.4%)
 Leg numbness 39 (56.5%)/49 (71.0%) 55 (53.9%)/75 (73.5%) 64 (50.0%)/85 (66.4%)
 Leg pain 7 (10.1%)/9 (13.0%) 12 (11.8%)/17 (16.7%) 29 (22.7%)/39 (30.5%)
 Gait disturbance 17 (24.6%)/44 (63.8%) 29 (28.4%)/79 (77.5%) 31 (24.2%)/68 (53.1%)
 Leg paresis 3 (4.3%)/16 (23.2%) 7 (6.9%)/53 (52.0%) 11 (8.6%)/32 (25.0%)
 BBD 1 (1.4%)/4 (5.8%) 3 (2.9%)/13 (12.7%) 5 (3.9%)/9 (7.0%)
Neurologic findings
 Hyper-PTR 56 (81.2%) 82 (80.4%) 57 (44.5%)
 Hyper-ATR 51 (73.9%) 74 (72.5%) 53 (41.4%)
 Positive ankle clonus 38 (55.1%) 53 (52.0%) 30 (23.4%)
Disease
 OLF 7 (10.1%) 3 (2.9%) 38 (29.7%)
 OPLL 8 (11.6%) 19 (18.6%) 3 (2.3%)
 OPLL + OLF 5 (7.2%) 18 (17.6%) 3 (2.3%)
 IET 24 (34.8%) 29 (28.4%) 45 (35.2%)
 IMSCT 16 (23.2%) 16 (15.7%) 32 (25.0%)
 VT 7 (10.1%) 7 (6.9%) 3 (2.3%)
 SCH 2 (2.9%) 5 (4.9%) 0 (0.0%)
 VF 0 (0.0%) 1 (1.0%) 3 (2.3%)
 TDH 0 (0.0%) 3 (2.9%) 2 (1.6%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, JOA = Japanese Orthopaedic Association, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Factors Related to Disease and Affected Level

Multivariate analyses were performed using the above variables to identify factors that were notably related to disease and affected level. In these analyses, there were significant associations of gait disturbance at initial diagnosis with OPLL (OR, 2.74, 95% CI, 1.16 to 6.50, P = 0.022) and OPLL + OLF (OR, 4.18, 95% CI, 1.66 to 10.53, P = 0.002) (Table 5 and Figure 1); back pain at initial diagnosis with disease at upper (OR, 2.31, 95% CI, 1.14 to 4.66, P = 0.02) and middle (OR, 2.22, 95% CI, 1.13 to 4.39, P = 0.02) levels; and low back pain with disease at a lower level (OR, 5.12, 95% CI, 2.47 to 10.60, P < 0.01) (Table 6 and Figure 2).

Table 5.

Factors Related to Disease Based on Multiple Logistic Regression Analysis

Disease Odds Ratio (95% Confidence Interval) P
OPLL Gait disturbance (initial) 2.74 (1.16-6.50) 0.022
OPLL + OLF Gait disturbance (initial) 4.18 (1.66-10.53) 0.002

OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament

Figure 1.

Figure 1

Bar graph showing that there were notable associations of gait disturbance at initial diagnosis with OPLL and OPLL + OLF; #P < 0.01. IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Table 6.

Factors Related to Affected Level Based on Multiple Logistic Regression Analysis

Affected level Odds Ratio (95% Confidence Interval) P
Upper Back pain (initial) 2.31 (1.14-4.66) 0.02
Middle Back pain (initial) 2.22 (1.13-4.39) 0.02
Lower Low back pain (initial) 5.12 (2.47-10.60) <0.01

Figure 2.

Figure 2

Bar graph showing that back pain at initial diagnosis with disease at a upper level and low back pain with disease at a lower level were significantly higher than another pain; #P < 0.01.

Discussion

Thoracic disease with myelopathy is relatively rare, and diagnosis may be delayed.10 The disease can be diagnosed by MRI and CT,11 but criteria are based on limited reports with relatively few patients with thoracic ossification, spondylosis, and disk herniation.1,2 In this study, we included other disorders that are causes of thoracic myelopathy, including spinal tumor, spinal cord tumor, trauma, ossification of the ligament, and SCH, in addition to these diseases, and we identified factors associated with these diseases by comparing symptoms and physical examination findings.

The mean disease duration of IMSCT and SCH tended to be longer than that for other diseases. These diseases are rare,1214 and the period until surgery may reflect the longer time required for diagnosis. Similarly, the shorter disease durations of VT, VF, and TDH may be linked to their relative ease of diagnosis using radiograph, MRI, and CT.15,16 As in a previous report, OLF occurred at lower levels of the thoracic spine and OPLL and OPLL + OLF at middle levels.1719 The reasons for the high frequency of OLF at lower thoracic levels include increased mechanical stress where the thoracic vertebrae form the junction between the rigid rib cage and elastic lumbar spine, a direct correlation between increased mobility of the spine and repetitive mild trauma, and high tensile force present in the posterior column.17 Matsumoto et al20 analyzed the surgical outcomes of patients with thoracic OPLL and found an average recovery rate of 36% and reduction of myelopathy immediately after surgery in 12% of patients. As preoperative myelopathy became severe, the JOA recovery rate became worse.

It is generally considered that PTR and ATR were hyper in patients with myelopathy. However, hyper-PTR, hyper-ATR, and positive ankle clonus occurred less frequently at the lower level in this study. The low rate of hyper-PTR, hyper-ATR, and positive ankle clonus may be explained by the involvement of conus and lumbar nerve roots.21 We should be aware of the possibility of lower thoracic diseases without hyper-PTR and hyper-ATR in thoracic myelopathy.

The number of symptoms just before surgery was higher than the number of initial symptoms. Moreover, an increase in the rate of change in preoperative symptoms compared with initial symptoms such as leg numbness, gait disturbance, leg paresis, and BBD was notably higher than that of girdle pain, back pain, and low back pain. In other words, it might mean the finding of increased neurologic compromise with no clear increase in the pain level at the time of surgery compared with the time of the initial diagnosis.

Gait disturbance at initial diagnosis, including leg palsy, leg numbness, posterior column ataxia, and spasticity, was notably associated with OPLL and OPLL + OLF. These are generally severe conditions because of spinal cord compression from the anterior or posterior side, which results in various symptoms. Gait disturbance is a representative symptom for patients with thoracic ossification.22 Back pain at initial diagnosis was notably associated with disease at the upper and middle levels, whereas low back pain was linked to disease at the lower level. The high prevalence of low back pain in patients with lower level disease may be explained by the involvement of the conus, which is a target for treatment of low back pain.23,24 Several case reports have indicated a relationship of back pain with upper and middle level disorders,25,26 and we speculate that a change in pressure in the spinal cord and vertebral column could lead to back pain.

To the best of our knowledge, this is the first report to examine factors related to diseases and levels that result in thoracic myelopathy. It was suggested that the increased neurologic compromise at the time of surgery compared with the time of the initial diagnosis was not associated with the pain level. Gait disturbance at initial diagnosis was associated with OPLL and OPLL + OLF. Back pain at initial diagnosis was associated with disease at the upper and middle levels, whereas low back pain was linked to disease at the lower level.

Conclusion

We examined the characteristic factors related to diseases at each level of the thoracic spine that can result in myelopathy, based on symptoms and physical examination findings. We should be aware of the possibility of lower thoracic diseases without hyper-PTR and hyper-ATR in thoracic myelopathy. The increased neurologic compromise at the time of surgery compared with the time of the initial diagnosis was not associated with the pain level. OPLL and OPLL + OLF were characterized by gait disturbance at initial diagnosis. Back pain at initial diagnosis was associated with upper and middle level disease, and low back pain was linked to lower level disease.

Footnotes

None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Ando, Dr. Kobayashi, Dr. Ito, Dr. Tsushima, Dr. Morozumi, Dr. Tanaka, Dr. Machino, Dr. Ota, Dr. Ishiguro, and Dr. Imagama.

References

  • 1.Hou X, Sun C, Liu X, et al. : Clinical features of thoracic spinal stenosis-associated myelopathy: A retrospective analysis of 427 cases. Clin Spine Surg 2016;29:86-89. [DOI] [PubMed] [Google Scholar]
  • 2.Takenaka S, Kaito T, Hosono N, et al. : Neurological manifestations of thoracic myelopathy. Arch Orthop Trauma Surg 2014;134:903-912. [DOI] [PubMed] [Google Scholar]
  • 3.Ando K, Imagama S, Wakao N, et al. : Examination of the influence of ossification of the anterior longitudinal ligament on symptom progression and surgical outcome of ossification of the thoracic ligamentum flavum: A multicenter study. J Neurosurg Spine 2012;16:147-153. [DOI] [PubMed] [Google Scholar]
  • 4.Matsuyama Y, Yoshihara H, Tsuji T, et al. : Surgical outcome of ossification of the posterior longitudinal ligament (OPLL) of the thoracic spine: Implication of the type of ossification and surgical options. J Spinal Disord Tech 2005;18:492-497; discussion 498. [DOI] [PubMed] [Google Scholar]
  • 5.Yonenobu K, Korkusuz F, Hosono N, Ebara S, Ono K: Lateral rhachotomy for thoracic spinal lesions. Spine (Phila Pa 1976) 1990;15:1121-1125. [DOI] [PubMed] [Google Scholar]
  • 6.Epstein NE: Patients with “Lumbar Stenosis” and unrecognized distal thoracic cord compression. Spinal Surg 2007;21:101-104. [Google Scholar]
  • 7.Toribatake Y, Baba H, Kawahara N, Mizuno K, Tomita K: The epiconus syndrome presenting with radicular-type neurological features. Spinal Cord 1997;35:163-170. [DOI] [PubMed] [Google Scholar]
  • 8.Hirabayashi K, Miyakawa J, Satomi K, Maruyama T, Wakano K: Operative results and postoperative progression of ossification among patients with ossification of cervical posterior longitudinal ligament. Spine (Phila Pa 1976) 1981;6:354-364. [DOI] [PubMed] [Google Scholar]
  • 9.Yonenobu K, Abumi K, Nagata K, Taketomi E, Ueyama K: Interobserver and intraobserver reliability of the Japanese Orthopaedic Association scoring system for evaluation of cervical compression myelopathy. Spine 2001;26:1890-1894; discussion 1895. [DOI] [PubMed] [Google Scholar]
  • 10.Yonenobu K, Ebara S, Fujiwara K, et al. : Thoracic myelopathy secondary to ossification of the spinal ligament. J Neurosurg 1987;66:511-518. [DOI] [PubMed] [Google Scholar]
  • 11.Guo JJ, Luk KD, Karppinen J, Yang H, Cheung KM: Prevalence, distribution, and morphology of ossification of the ligamentum flavum: A population study of one thousand seven hundred thirty-six magnetic resonance imaging scans. Spine (Phila Pa 1976) 2010;35:51-56. [DOI] [PubMed] [Google Scholar]
  • 12.Imagama S, Matsuyama Y, Sakai Y, et al. : Image classification of idiopathic spinal cord herniation based on symptom severity and surgical outcome: A multicenter study. J Neurosurg Spine 2009;11:310-319. [DOI] [PubMed] [Google Scholar]
  • 13.Nakashima H, Imagama S, Yagi H, et al. : Clinical and radiographical differences between thoracic idiopathic spinal cord herniation and spinal arachnoid cyst. Spine (Phila Pa 1976) 2017;42:E963-E968. [DOI] [PubMed] [Google Scholar]
  • 14.Naruse T, Matsuyama Y, Ishiguro N: Cyclooxygenase-2 expression in ependymoma of the spinal cord. J Neurosurg Spine 2007;6:240-246. [DOI] [PubMed] [Google Scholar]
  • 15.Laufer I, Zuckerman SL, Bird JE, et al. : Predicting neurologic recovery after surgery in patients with deficits secondary to MESCC: Systematic Review. Spine 2016;41(suppl 20):S224–S230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Oppenlander ME, Clark JC, Kalyvas J, Dickman CA: Surgical management and clinical outcomes of multiple-level symptomatic herniated thoracic discs. J Neurosurg Spine 2013;19:774-783. [DOI] [PubMed] [Google Scholar]
  • 17.Ando K, Imagama S, Ito Z, et al. : Predictive factors for a poor surgical outcome with thoracic ossification of the ligamentum flavum by multivariate analysis: A multicenter study. Spine (Phila Pa 1976) 2013;38:E748-E754. [DOI] [PubMed] [Google Scholar]
  • 18.Mori K, Kasahara T, Mimura T, et al. : Prevalence, distribution, and morphology of thoracic ossification of the yellow ligament in Japanese: Results of CT-based cross-sectional study. Spine (Phila Pa 1976) 2013;38:E1216-E1222. [DOI] [PubMed] [Google Scholar]
  • 19.Mori K, Imai S, Kasahara T, Nishizawa K, Mimura T, Matsusue Y: Prevalence, distribution, and morphology of thoracic ossification of the posterior longitudinal ligament in Japanese: Results of CT-based cross-sectional study. Spine (Phila Pa 1976) 2014;39:394-399. [DOI] [PubMed] [Google Scholar]
  • 20.Matsumoto M, Chiba K, Toyama Y, et al. : Surgical results and related factors for ossification of posterior longitudinal ligament of the thoracic spine: A multi-institutional retrospective study. Spine (Phila Pa 1976) 2008;33:1034-1041. [DOI] [PubMed] [Google Scholar]
  • 21.Wall EJ, Cohen MS, Abitbol JJ, Garfin SR: Organization of intrathecal nerve roots at the level of the conus medullaris. J Bone Joint Surg Am 1990;72:1495-1499. [PubMed] [Google Scholar]
  • 22.Imagama S, Ando K, Kobayashi K: Factors for a good surgical outcome in posterior decompression and dekyphotic corrective fusion with instrumentation for thoracic ossification of the posterior longitudinal ligament: Prospective single-center study. Oper Neurosurg (Hagerstown) 2017:13:661-669. [DOI] [PubMed] [Google Scholar]
  • 23.Murata Y, Kato Y, Miyamoto K, Takahashi K: Clinical study of low back pain and radicular pain pathways by using l2 spinal nerve root infiltration: A randomized, controlled, clinical trial. Spine (Phila Pa 1976) 2009;34:2008-2013. [DOI] [PubMed] [Google Scholar]
  • 24.Ohtori S, Nakamura S, Koshi T, et al. : Effectiveness of L2 spinal nerve infiltration for selective discogenic low back pain patients. J Orthop Sci 2010;15:731-736. [DOI] [PubMed] [Google Scholar]
  • 25.Freedman BA, Malone DG, Rasmussen PA, Cage JM, Benzel EC: Surfer's myelopathy: A rare form of spinal cord infarction in novice surfers: A systematic review. Neurosurgery 2016;78:602-611. [DOI] [PubMed] [Google Scholar]
  • 26.Noël P, Preux G, Thézé A: Epidural lipomatosis: A possible cause of back pain. Ann Phys Rehabil Med 2014;57:734-737. [DOI] [PubMed] [Google Scholar]

Articles from JAAOS Global Research & Reviews are provided here courtesy of Wolters Kluwer Health

RESOURCES